Jazz Pharmaceuticals
JAZZ
#2111
Rank
A$11.61 B
Marketcap
$192.07
Share price
-2.65%
Change (1 day)
0.46%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.00

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.18. In 2022 the company made an earnings per share (EPS) of -$5.47 an increase over its 2021 EPS that were of -$8.32.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.00-63.37%
2022-$5.47-34.2%
2021-$8.32-224.83%
2020$6.66-53.25%
2019$14.2523.59%
2018$11.53-8.24%
2017$12.5723.74%
2016$10.1522.12%
2015$8.32478.49%
2014$1.44-74.93%
2013$5.73-27.11%
2012$7.8769.1%
2011$4.65245.98%
2010$1.34-462.5%
2009-$0.37-96.7%
2008-$11.25-27.04%
2007-$15.4265.47%
2006-$9.32-4.59%
2005-$9.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.21 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$12.81-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.78-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.09 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel